News Releases

August 19, 2025

Vets and Pet-Owners See Gaps in Flea and Tick Prevention, Highlighting Need for Year-Round Care, New Merck Animal Health Global Survey Finds

Data show pet owners face difficulties with consistent compliance, while veterinarians worry about inconsistent or incorrect medication administration In the U.S. Two-thirds of veterinarians note that most pet owners do not follow year-round treatment plan, despite evidence that fleas and tick are present during all seasons RAHWAY, N.J., August 19, 2025 – Merck Animal Health, […]

August 18, 2025

Merck Animal Health Presents New Data Highlighting Commitment to the Development and Study of Parasite Prevention and Treatment for Dogs at the 2025 World Association for the Advancement of Veterinary Parasitology Congress

Data to showcase depth and breadth of the BRAVECTO® (fluralaner) portfolio including the injectable and oral endectocide combination formulations RAHWAY, N.J., August 18, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will […]

July 10, 2025

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

12-Month Parasiticide Treatment for Dogs Offers Unrivaled Duration of Flea and Tick Protection Compared to Existing Products RAHWAY, N.J., July 10, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and […]

May 2, 2025

FDA Approves Merck Animal Health’s MOMETAMAX SINGLE™ to Treat Otitis Externa in Dogs

The leading manufacturer of otic treatments expands portfolio with the only FDA-approved, one dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens RAHWAY, N.J., May 02, 2025 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced […]

November 26, 2024

Merck Animal Health Announces European Approval of BRAVECTO® TriUNO for Use in Dogs

The new formulation targets internal and external parasites, expanding the BRAVECTO® portfolio RAHWAY, N.J., November 26, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for […]

September 27, 2024

Merck Animal Health Reaffirms its Commitment to Eliminating Rabies with its 6 Millionth Vaccine Donation Through the Afya Program

RAHWAY, N.J., September 28, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than six million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. “Many communities where rabies […]

June 25, 2024

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease RAHWAY, N.J., June 25, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Department of Agriculture (USDA) approval of NOBIVAC® […]

June 17, 2024

Merck Animal Health Announces Launch and Availability of NOBIVAC® NXT Rabies in Canada

First-of-its-kind line of vaccines leverages state-of-the-art RNA-particle technology to protect cats and dogs from rabies RAHWAY, N.J., June 17, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the launch and availability of the […]

March 18, 2024

Merck Animal Health Marks Commitment to Rabies Elimination Through Donation of NOBIVAC® Rabies Vaccines to Mission Rabies

Rahway, NJ., March 18, 2024 – Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK) has announced a continued commitment to rabies elimination through a donation of NOBIVAC® rabies vaccines to the Mission Rabies program, a charity initiative of the Worldwide Veterinary Service (WVS). The donations will continue over the […]

March 15, 2024

Orally Administered BRAVECTO® (Fluralaner) 12-Week Chew Eliminated 100 Percent of Brown Dog Ticks from Infested Kennels Housing Treated Dogs in Recently Published Study

BRAVECTO eliminated kennel infestations of brown dog ticks (Rhipicephalus sanguineus sensu lato) External imidacloprid/flumethrin collar treatments failed to eliminate all ticks from kennels RAHWAY, N.J., March 15, 2024 – Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), […]